Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients

Bojan Lazarevic, Allison R. Casola and Christopher V. Chambers
The Journal of the American Board of Family Medicine January 2024, jabfm.2023.230028R1; DOI: https://doi.org/10.3122/jabfm.2023.230028R1
Bojan Lazarevic
From the Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA (BL); Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA (ARC, CVC).
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison R. Casola
From the Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA (BL); Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA (ARC, CVC).
PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher V. Chambers
From the Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA (BL); Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA (ARC, CVC).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Demographic Information of Immunocompromised Patients (n = 887) by Vaccination Status

    Total ≥ 3 mRNA Vaccines ≤2 mRNA Vaccines
    n(%)n(%)n(%)p-Value
    Total887(100.0)556(62.7)331(37.3)--
    Race*
     White227(25.6)170(74.9)57(25.1)0.1292
     Black or African American591(66.7)343(58.0)248(42.0)
     Hispanic43(4.8)28(65.1)15(35.9)
     Asian21(2.4)13(61.9)8(38.1)
     American Indian or Alaskan Native4(0.5)4(100.0)0(0.0)
     Other/Unknown7(0.8)3(42.9)4(57.1)
    Age, y
     20–2922(2.5)4(18.2)18(81.9)0.1124
     30–3948(5.4)14(29.2)34(70.8)
     40–4989(10.0)42(47.2)47(52.8)
     50–59184(20.7)112(60.9)72(39.1)
     60–69258(29.1)172(66.7)86(33.3)
     70–79203(22.9)145(71.4)58(28.6)
     80+83(9.4)67(80.7)16(19.3)
    Sex
     Female391(44.1)236(60.4)155(39.6)0.1738
     Male496(55.9)320(64.5)176(35.5)
    Diagnosis†
     Hematologic cancers‡12(1.4)9(75.0)3(25.0)0.2428
     Solid tumor cancers§555(62.6)371(66.8)184(33.2)
     Autoimmune disorders‖30(3.4)19(63.3)11(36.7)
     Solid organ transplant recipients¶46(5.2)29(63.0)17(37.0)
     HIV/AIDS211(23.8)122(57.8)89(42.2)
     Patients on Dialysis94(10.6)43(45.7)51(54.3)
    • ↵Notes. *Some patients identified with more than one race, so the values in this category add up to greater than the total sample size.

    • ↵†Patients may have had more than one diagnosis, so the values in this category add up to greater than the total sample size.

    • ↵‡Diagnoses included in this category: diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML).

    • ↵§ Diagnoses included in this category: breast cancer, lung cancer, prostate cancer, colorectal cancer, melanoma, bladder cancer, head and neck cancer.

    • ↵‖ Diagnoses included in this category: autoimmune hepatitis, psoriatic arthritis, spondyloarthritis, ankylosing spondylitis, rheumatoid arthritis, primary biliary cholangitis, dermatomyositis, systemic lupus erythematosus, primary Sjögren’s syndrome, systemic sclerosis.

    • ↵¶ Transplants included in this category: kidney, liver, heart/lung, pancreas.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 37 (6)
The Journal of the American Board of Family Medicine
Vol. 37, Issue 6
November-December 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients
Bojan Lazarevic, Allison R. Casola, Christopher V. Chambers
The Journal of the American Board of Family Medicine Jan 2024, jabfm.2023.230028R1; DOI: 10.3122/jabfm.2023.230028R1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients
Bojan Lazarevic, Allison R. Casola, Christopher V. Chambers
The Journal of the American Board of Family Medicine Jan 2024, jabfm.2023.230028R1; DOI: 10.3122/jabfm.2023.230028R1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Successful Implementation of Integrated Behavioral Health
Show more Original Research

Similar Articles

Keywords

  • COVID-19
  • COVID-19 Vaccines
  • Immunocompromised Patient
  • Retrospective Studies
  • Vaccination

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire